To bring efficiency to the drug development process by connecting the wealth of research data, clinical evidence, cell lines, -omics and drug failures in designing meaningful assays that add value in accelerating drugs into the clinic
Our Mission
Our capabilities
Our infrastructure is equipped with state-of-the-art equipment necessary to conduct any preclinical research studies.
Our Mission
“Our mission as a team is to be the leader in developing and providing our partners with translational systems to accelerate immuno-oncology (IO) research. We tailor our model systems to fit the needs of our partners by offering a unique set of cell chains and providing detailed reports with our findings.”
Our Objectives
- Streamline the IND-enabling process by providing the “tool box” of cells, assays, model systems.
- Connect the immunology “dots” in developing a drug profile for our partners.
- Be innovative and cost-effective in our approach to services.
- Think like a biotech
What is Immuno-Oncology (IO)?
Immuno-oncology is a method of immunotherapy used to target and treat various cancers. This method works in a different way than more traditional ways of fighting cancer, such as chemotherapy or radiation. IO uses the body’s own immune system to fight against cancerous cells.
What are the challenges in IO?
The goal of immunotherapy is to attract T cells to kill tumors. However, recent advances in our understanding of IO have identified several factors such as the tumor immune microenvironment and competing cell types that impede the ability of T cells to do their job effectively. We aim to identify and develop assays and systems that can capture these factors and screen drug candidates.
Frequently asked Questions (FAQ)
How can I receive your Schedule of Assays?
Please sign up onto our mailing list via our website and you will receive our upcoming schedule.
What do I need to have in place before working with Immunaccel?
A Master Services Agreement (MSA), a Purchase Order (PO) number and signed Statement of Work (SOW) are required to initiate a study. We can work with your MSA template or can provide ours.
How can I Build-a-System?
Once you select a cell platform, you can send us a draft protocol or design concept. Our team will review and provide an estimate?
How can I reserve a position in your Schedule Assay run?
Our Schedule Assays are on a first-come, first-serve basis. If we have an MSA in place – it’s easy. Simply send our team an e-mail and we will get back to you on the availability.
When can I expect my results?
For our Scheduled Assay runs we expect a 2-3 week turnaround. More complex projects are handled on a case-by-case basis.
Can you procure patient samples in other cancer types?
Yes – please contact us to discuss your interests in the context of our assay platforms.
Can I license your cell platforms?
Depending on the scope of projects – we can consider licensing our cell platforms under a partnership.
Do you sell patient samples for research use?
No – Immunaccel is not in the business of selling patient derived samples.
We are always seeking strategic investors who understand our mission and objectives.
Why work with Immunaccel?
HOW CAN WE WORK WITH YOU?
